Senseonics Holdings (SENS) Debt Ratio (2014 - 2024)
Senseonics Holdings (SENS) reported Debt Ratio of 0.0 for Q1 2024, up 616.22% on a QoQ basis from 0.0 in Q4 2022.
Senseonics Holdings (SENS) has 8 years of Debt Ratio data on file, last reported at 0.0 in Q1 2024.
- Quarterly Debt Ratio changed N/A year-over-year to 0.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was 0.0 (changed N/A YoY) and the FY2022 annual result came in at 0.0, changed N/A from the prior year.
- Debt Ratio rose to 0.0 in Q1 2024 per SENS's latest filing, from 0.0 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.01 in Q1 2022 and bottomed at 0.0 in Q4 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Senseonics Holdings | 316.18 Mn | 251.85 Mn | 6.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 0.00 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2019 | 0.45 |
| Sep 30, 2019 | 0.26 |
| Mar 31, 2019 | 0.02 |
| Dec 31, 2018 | 0.03 |
| Sep 30, 2018 | 0.04 |
| Jun 30, 2018 | 0.05 |
| Mar 31, 2018 | 0.15 |
| Dec 31, 2017 | 0.31 |
| Sep 30, 2017 | 0.28 |
| Jun 30, 2017 | 0.41 |
| Mar 31, 2017 | 1.33 |
| Dec 31, 2016 | 0.68 |
| Sep 30, 2016 | 0.46 |
| Jun 30, 2016 | 0.38 |
| Mar 31, 2016 | 0.20 |
| Dec 31, 2015 | 1.37 |
| Dec 31, 2014 | 0.49 |